Actively Recruiting

Age: 18Years - 70Years
All Genders
ID06667557

Comparison of Superpulse Thulium Fiber Laser and Holmium:YAG Laser Lithotripsy for Kidney and Upper Ureteral Stones During Flexible Ureteroscopy

Led by Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Updated on 2026-01-21

136

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to compare the clinical effectiveness and safety of two types of lasers, superpulse thulium fiber laser (sTFL) and holmium:YAG laser (Ho:YAG), used during flexible ureteroscopy (FURS) lithotripsy for adults aged 18 to 70 years with kidney or upper ureteral stones measuring 6-20mm. The study focuses on whether sTFL results in a higher stone-free rate three months after surgery, as well as differences in operation time, complication rates, and the surgeon's visual experience. Participants will be randomly assigned to receive FURS lithotripsy using either the sTFL or Ho:YAG laser under general anesthesia. Experienced urologists will perform all procedures, adjusting laser settings based on the stone characteristics to optimize treatment. The study includes several visits: a baseline screening, intraoperative procedure, postoperative monitoring within 24 hours, and follow-up visits at 3 and 6 months to assess stone clearance and recurrence using CT scans. During the study, participants will undergo CT scans at 3 and 6 months post-operation to check for remaining stones and recurrence. Researchers will monitor vital signs, document any complications using the Clavien-Dindo classification, and evaluate the surgeon's visual experience concerning clarity, efficiency, stone movement, and tissue injury. Adverse events will be recorded throughout the study, which is expected to last until October 2028.

CONDITIONS

Brief Title

Comparing Super Pulse Fiber Thulium Laser and Holmium Laser for Ureteral Stone Fragmentation During Ureteroscopy

Who Can Participate

Age: 18Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Diagnosed with kidney stones and/or upper ureteral stones between 6mm and 20mm in size
  • Planned to undergo flexible ureteroscopy lithotripsy
  • Willing to have the procedure under general anesthesia
  • Negative urine culture before surgery
  • Provided signed informed consent to participate in the study
Not Eligible

You will not qualify if you...

  • Having only one kidney
  • Previous kidney transplant or urinary diversion surgery
  • Congenital malformations of the urinary system
  • Abnormal blood clotting due to blood or liver diseases
  • Severe heart or lung disease, cancer, or immune deficiency
  • Neurogenic bladder condition
  • Unable or unwilling to provide informed consent
  • Untreated urinary tract infection
  • Known urinary tract abnormalities like ureteral stenosis or urothelial tumors
  • Stones removable without laser lithotripsy
  • Pregnant women
  • Stones unreachable with flexible negative pressure suction or conventional sheath
  • Surgery performed under epidural or lumbar anesthesia
  • Recurrent stones caused by genetic metabolic diseases

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 baseline visit (in-person)

Implementation

Duration - Day of surgery

Participants undergo flexible ureteroscopy with either superpulse thulium fiber laser or holmium:YAG laser for kidney and upper ureteral stone fragmentation. During the procedure, operation time, laser type, surgeon's visual experience, vital signs, and complications are recorded.

1 intraoperative visit (in-person) and monitoring within 24 hours post-surgery

Follow-up

Duration - Up to 6 months after surgery

Participants return for follow-up visits to assess stone clearance and recurrence using CT scans, and to monitor for any complications or adverse events.

2 visits at 3 months and 6 months (in-person)

Trial Site Locations

Total: 1 location

1

Shanghai General Hospital

Shanghai, Shanghai Municipality, China, 201620

Actively Recruiting

Loading map...

Research Team

R

Ruixuan Zhu

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here